JP2023510218A5 - - Google Patents
Info
- Publication number
- JP2023510218A5 JP2023510218A5 JP2022540870A JP2022540870A JP2023510218A5 JP 2023510218 A5 JP2023510218 A5 JP 2023510218A5 JP 2022540870 A JP2022540870 A JP 2022540870A JP 2022540870 A JP2022540870 A JP 2022540870A JP 2023510218 A5 JP2023510218 A5 JP 2023510218A5
- Authority
- JP
- Japan
- Prior art keywords
- human insulin
- γglu
- desb30 human
- eicosanedioyl
- ethoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911397405.2 | 2019-12-30 | ||
| CN201911397405 | 2019-12-30 | ||
| CN202011053306 | 2020-09-29 | ||
| CN202011053306.5 | 2020-09-29 | ||
| PCT/CN2020/141057 WO2021136303A1 (zh) | 2019-12-30 | 2020-12-29 | 长效glp-1化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023510218A JP2023510218A (ja) | 2023-03-13 |
| JP2023510218A5 true JP2023510218A5 (enExample) | 2025-10-27 |
Family
ID=76687327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022540870A Pending JP2023510218A (ja) | 2019-12-30 | 2020-12-29 | 長時間作用型ｇｌｐ－１化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20240239859A1 (enExample) |
| EP (1) | EP4086277A4 (enExample) |
| JP (1) | JP2023510218A (enExample) |
| KR (1) | KR20220119731A (enExample) |
| CN (5) | CN119060162A (enExample) |
| AU (1) | AU2020418207A1 (enExample) |
| BR (1) | BR112022013042A2 (enExample) |
| CA (1) | CA3166496A1 (enExample) |
| MX (1) | MX2022008139A (enExample) |
| WO (1) | WO2021136303A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118754967A (zh) * | 2019-12-30 | 2024-10-11 | 甘李药业股份有限公司 | 胰岛素衍生物 |
| EP4086277A4 (en) * | 2019-12-30 | 2024-02-14 | Gan & Lee Pharmaceuticals Co., Ltd. | Long-acting glp-1 compound |
| CA3204051A1 (en) | 2021-01-20 | 2022-07-28 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| CN117561072A (zh) * | 2021-06-25 | 2024-02-13 | 甘李药业股份有限公司 | 含glp-1化合物的药物组合物 |
| JP7642830B2 (ja) | 2021-09-15 | 2025-03-10 | バイキング・セラピューティクス・インコーポレイテッド | 代謝及び肝臓障害の処置のための組成物及び方法 |
| US20250115654A1 (en) * | 2021-11-12 | 2025-04-10 | Fujian Shengdi Pharmaceutical Co., Ltd. | Pharmaceutical composition of glp-1 receptor and gip receptor dual agonist, and use thereof |
| US20250340610A1 (en) * | 2022-01-28 | 2025-11-06 | Gan & Lee Pharmaceuticals Co., Ltd. | Acylated insulin |
| WO2024179606A1 (zh) * | 2023-03-02 | 2024-09-06 | 甘李药业股份有限公司 | 一种glp-1化合物的医药用途 |
| CN121219311A (zh) * | 2023-05-24 | 2025-12-26 | 联邦生物科技(珠海横琴)有限公司 | 一种胰岛素衍生物及其应用 |
| CN121464152A (zh) * | 2023-06-30 | 2026-02-03 | 株式会社汇恩斯拉布 | 以glp类似物为有效成分的用于预防或治疗肥胖的药物组合物 |
| WO2025098415A1 (zh) * | 2023-11-06 | 2025-05-15 | 甘李药业股份有限公司 | 用于降糖的glp-1化合物 |
| WO2025098416A1 (zh) * | 2023-11-06 | 2025-05-15 | 甘李药业股份有限公司 | 用于减肥的glp-1化合物 |
| WO2025098457A1 (zh) * | 2023-11-07 | 2025-05-15 | 甘李药业股份有限公司 | 用于降糖的酰化胰岛素 |
| WO2025098502A1 (zh) * | 2023-11-08 | 2025-05-15 | 甘李药业股份有限公司 | 包含胰岛素衍生物的药物组合物的治疗用途 |
| TW202529797A (zh) * | 2023-12-12 | 2025-08-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | Ｇｌｐ－１類似物治療代謝疾病的方法及醫藥用途 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ199391A (en) | 1981-01-02 | 1985-12-13 | Genentech Inc | Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin |
| DK58285D0 (da) | 1984-05-30 | 1985-02-08 | Novo Industri As | Peptider samt fremstilling og anvendelse deraf |
| PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| DK336188D0 (da) | 1988-06-20 | 1988-06-20 | Nordisk Gentofte | Propeptider |
| HUT56857A (en) | 1988-12-23 | 1991-10-28 | Novo Nordisk As | Human insulin analogues |
| IL93282A (en) | 1989-02-09 | 1995-08-31 | Lilly Co Eli | Insulin analogues |
| EP1132404A3 (en) | 1993-09-17 | 2002-03-27 | Novo Nordisk A/S | Acylated insulin |
| WO1995016708A1 (en) | 1993-12-17 | 1995-06-22 | Novo Nordisk A/S | Proinsulin-like compounds |
| US6500645B1 (en) | 1994-06-17 | 2002-12-31 | Novo Nordisk A/S | N-terminally extended proteins expressed in yeast |
| KR0150565B1 (ko) | 1995-02-15 | 1998-08-17 | 김정재 | 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법 |
| EP0741188A3 (en) | 1995-05-05 | 1999-07-14 | Eli Lilly And Company | Single chain insulin with high bioactivity |
| IL128332A0 (en) | 1996-08-30 | 2000-01-31 | Novo Nordisk As | GLP-1 derivatives |
| JP2003522099A (ja) | 1998-02-27 | 2003-07-22 | ノボ ノルディスク アクティーゼルスカブ | 遅延作用プロファイルを有するｇｌｐ−１のｇｌｐ−１誘導体及びエキセンジン |
| CA2572770A1 (en) * | 2004-07-08 | 2006-01-19 | Novo-Nordisk A/S | Polypeptide protracting tags comprising a tetrazole moiety |
| TWI362392B (en) * | 2005-03-18 | 2012-04-21 | Novo Nordisk As | Acylated glp-1 compounds |
| US9150633B2 (en) * | 2007-08-15 | 2015-10-06 | Novo Nordisk A/S | Insulin analogues with an acyl and alkylene glycol moiety |
| JP5721432B2 (ja) * | 2007-08-15 | 2015-05-20 | ノボ・ノルデイスク・エー／エス | アミノ酸含有アルキレングリコール反復単位を含むアシル部を有するインスリン |
| WO2009030771A1 (en) * | 2007-09-05 | 2009-03-12 | Novo Nordisk A/S | Peptides derivatized with a-b-c-d- and their therapeutical use |
| US20100292133A1 (en) * | 2007-09-05 | 2010-11-18 | Novo Nordisk A/S | Truncated glp-1 derivaties and their therapeutical use |
| HUE032284T2 (en) * | 2008-03-18 | 2017-09-28 | Novo Nordisk As | Protease-stabilized, acylated insulin analogues |
| US8788849B2 (en) * | 2011-02-28 | 2014-07-22 | Sandisk Technologies Inc. | Method and apparatus for protecting cached streams |
| EP2866825B1 (en) * | 2012-07-01 | 2020-04-08 | Novo Nordisk A/S | Use of long-acting glp-1 peptides |
| ES2908373T3 (es) * | 2015-08-25 | 2022-04-28 | Novo Nordisk As | Nuevos derivados de insulina y los usos médicos de los mismos |
| EP3922260A3 (en) * | 2016-05-24 | 2022-06-15 | Merck Sharp & Dohme Corp. | Insulin receptor partial agonists and glp-1 analogues |
| PE20210857A1 (es) * | 2016-12-16 | 2021-05-18 | Novo Nordisk As | Composiciones farmaceuticas que contienen insulina |
| CN109248323B (zh) * | 2017-07-14 | 2023-09-08 | 杭州先为达生物科技有限公司 | 酰化的glp-1衍生物 |
| WO2019200594A1 (zh) * | 2018-04-19 | 2019-10-24 | 杭州先为达生物科技有限公司 | 酰化的glp-1衍生物 |
| CN118754967A (zh) * | 2019-12-30 | 2024-10-11 | 甘李药业股份有限公司 | 胰岛素衍生物 |
| EP4086277A4 (en) * | 2019-12-30 | 2024-02-14 | Gan & Lee Pharmaceuticals Co., Ltd. | Long-acting glp-1 compound |
-
2020
- 2020-12-29 EP EP20909624.7A patent/EP4086277A4/en active Pending
- 2020-12-29 JP JP2022540870A patent/JP2023510218A/ja active Pending
- 2020-12-29 CN CN202411172489.0A patent/CN119060162A/zh active Pending
- 2020-12-29 BR BR112022013042A patent/BR112022013042A2/pt unknown
- 2020-12-29 AU AU2020418207A patent/AU2020418207A1/en active Pending
- 2020-12-29 CN CN202411172407.2A patent/CN119060161A/zh active Pending
- 2020-12-29 CN CN202080091240.0A patent/CN114901680B/zh active Active
- 2020-12-29 CN CN202411172451.3A patent/CN119529057A/zh active Pending
- 2020-12-29 US US17/758,113 patent/US20240239859A1/en active Pending
- 2020-12-29 CN CN202411172559.2A patent/CN119060163A/zh active Pending
- 2020-12-29 WO PCT/CN2020/141057 patent/WO2021136303A1/zh not_active Ceased
- 2020-12-29 MX MX2022008139A patent/MX2022008139A/es unknown
- 2020-12-29 CA CA3166496A patent/CA3166496A1/en active Pending
- 2020-12-29 KR KR1020227026310A patent/KR20220119731A/ko active Pending
-
2024
- 2024-09-12 US US18/883,592 patent/US20250011385A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023510218A5 (enExample) | ||
| US20250011385A1 (en) | Long-Acting GLP-1 Compound | |
| US20250032589A1 (en) | Insulin Derivative | |
| JP2023510219A5 (enExample) | ||
| JP2023510206A5 (enExample) | ||
| JP2007537142A (ja) | アルブミン様物質に結合した新規のｇｌｐ−１類似物 | |
| US20250340610A1 (en) | Acylated insulin | |
| CN118684758A (zh) | 肠促胰岛素类似物及其应用 | |
| PL198190B1 (pl) | Analogi insuliny, sposób ich wytwarzania, prekursory analogów insuliny, sekwencje DNA kodujące te prekursory, wektory ekspresyjne, komórka gospodarza, środek farmaceutyczny, roztwór o aktywności insulinowej, zastosowanie analogów insuliny, kompleksy insuliny z cynkiem i ich zastosowanie | |
| HK40115534A (zh) | 长效glp-1化合物 | |
| EA050234B1 (ru) | Препараты glp-1 длительного действия | |
| EA050813B1 (ru) | Производное инсулина | |
| EA050726B1 (ru) | Производное инсулина | |
| HK40070502A (zh) | 胰岛素衍生物 |